creating crypto coin Top Related searches

Hang Seng Science and Technology Index rose to 1%, while Kewang shares rose, with Billie Billie (09626.HK) rising by over 4%, Baidu (09888.HK) rising by 2.8%, Aauto Quicker (01024.HK), Tencent Holdings (00700.HK) rising by 1.8% and Alibaba (09988.HK) rising by over 1%.The trading of traditional Chinese medicine has increased the daily limit of Panlong Pharmaceutical, the trading of traditional Chinese medicine has increased, Panlong Pharmaceutical has increased its daily limit, Xiangxue Pharmaceutical has increased by over 9%, and Kunyao Group, Weikang Pharmaceutical, Huasen Pharmaceutical and Xinguang Pharmaceutical have followed suit.The total investment scale of Haiyouwei's factory in the United States may reach 10 million US dollars. According to Haiyouwei Science and Technology, on December 11th, Haiyouwei announced that it planned to set up a subsidiary in the United States to implement the polymer special membrane project. This project is a deepening cooperation between Haiyouwei and its industry partners on the basis of strategic and technical cooperation in the United States. It is an important measure to achieve the localized production and market-oriented extension of the company's photovoltaic packaging film in the American market. It is estimated that the total investment will not exceed 10 million US dollars.

Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.The project of Chuangpu Instrument Industrial Park started in Hefei, with a total investment of 320 million yuan. According to the news of Hefei High-tech Zone Management Committee, on December 10th, the project of Chuangpu Instrument Industrial Park at the intersection of Caihong West Road and Peacock Terrace Road in Hefei High-tech Zone officially started. The total investment of the project is 320 million yuan, which is planned to be completed at one time and is expected to be put into use in the second half of 2027.

Zhengzhou plans to identify three 4A-level scenic spots. On December 12th, it was reported that through the procedures of "voluntary declaration, step-by-step recommendation, landscape review, on-site inspection and party group research", Zhengzhou Municipal Bureau of Culture, Radio, Film and Tourism plans to identify three scenic spots, including Zhongmu Zhengzhou Haichang Ocean Park, Gongyi Qinglong Mountain Ecological Tourism Zone and Guancheng Zhengzhou Shangdu Ancient City Tourist Zone, as national 4A-level tourist attractions. The publicity period is 5 working days from December 9.Consumer stocks in Hong Kong stocks fluctuated higher, with the same journey rising by more than 6%, Mengniu Dairy rising by more than 4%, and China Resources Beer, Master Kong Holdings and Haidilao rising.Zhengzhou plans to identify three 4A-level scenic spots. On December 12th, it was reported that through the procedures of "voluntary declaration, step-by-step recommendation, landscape review, on-site inspection and party group research", Zhengzhou Municipal Bureau of Culture, Radio, Film and Tourism plans to identify three scenic spots, including Zhongmu Zhengzhou Haichang Ocean Park, Gongyi Qinglong Mountain Ecological Tourism Zone and Guancheng Zhengzhou Shangdu Ancient City Tourist Zone, as national 4A-level tourist attractions. The publicity period is 5 working days from December 9.